DOI: https://dx.doi.org/10.18203/2320-6012.ijrms20221803
Published: 2022-06-28

Curcumin in the patient with perennial allergic rhinitis with chronic episodic allergic asthma

Pradyut Waghray, Kunal Waghray, Jyotika Waghray

Abstract


A 24-year-old man presented with history of severe wheezing in the last 5 days. He had a history of skin allergy since childhood. He had a strong family history of similar complaints present in mother and other sibling. He was diagnosed with allergic rhinitis. He regularly uses ICS/LABA inhaler and fluticasone nasal spray, tablet bilastine 20 mg once daily and oral bronchodilators frequently. Bioavailable curcumin was added to his usual treatment regimen. Bio AV curcumin tab 500 mg (from Edence Life Sciences Pvt Ltd) twice daily was prescribed for 2 months. Curcumin was added to his usual treatment regimen. Curcumin Bio AV tab 500 mg twice daily was prescribed for 2 months followed by once daily dosing regimen which he continued even at 4 months follow up. After giving curcumin his oral steroids requirements reduced significantly while he continues the inhaled medications. Curcumin has potent anti-inflammatory and anti-allergic effects. Curcumin relieves the symptoms of both asthma and allergic rhinitis. Curcumin was found to exert diverse immunomodulatory effects in these disorders. Curcumin can have a place in the management of allergic rhinitis and asthma.


Keywords


Allergic rhinitis, Asthma, Curcumin

Full Text:

PDF

References


Sur DK, Plesa ML. Treatment of Allergic Rhinitis. Am Fam Physician. 2015;92(11):985-92.

Islam R, Dash D, Singh R. Intranasal curcumin and sodium butyrate modulates airway inflammation and fibrosis via HDAC inhibition in allergic asthma. Cytokine. 2022;149:155720.

Subhashini, Chauhan PS, Kumari S, Kumar JP, Chawla R, Dash D, Singh M, Singh R. Intranasal curcumin and its evaluation in murine model of asthma. Int Immunopharmacol. 2013;17(3):733-43.

Jagetia GC, Aggarwal BB. "Spicing up" of the immune system by curcumin. J Clin Immunol. 2007;27(1):19-35.

Chauhan PS, Singh DK, Dash D, Singh R. Intranasal curcumin regulates chronic asthma in mice by modulating NF-ĸB activation and MAPK signaling. Phytomedicine. 2018;51:29-38.

Subhashini, Chauhan PS, Dash D, Paul BN, Singh R. Intranasal curcumin ameliorates airway inflammation and obstruction by regulating MAPKinase activation (p38, Erk and JNK) and prostaglandin D2 release in murine model of asthma. Int Immunopharmacol. 2016;31:200-6.

Oh SW, Cha JY, Jung JE, Chang BC, Kwon HJ, Lee BR, Kim DY. Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-κB inhibition. J Ethnopharmacol. 2011;136(3):414-21.

Zhu T, Chen Z, Chen G, Wang D, Tang S, Deng H et al. Curcumin Attenuates Asthmatic Airway Inflammation and Mucus Hypersecretion Involving a PPARγ-Dependent NF-κB Signaling Pathway In Vivo and In Vitro. Mediators Inflamm. 2019;2019:4927430.

Abidi A, Gupta S, Agarwal M, Bhalla HL, Saluja M. Evaluation of Efficacy of Curcumin as an Add-on therapy in Patients of Bronchial Asthma. J Clin Diagn Res. 2014;8(8):HC19-24.

Zeng X, Cheng Y, Qu Y, Xu J, Han Z, Zhang T. Curcumin inhibits the proliferation of airway smooth muscle cells in vitro and in vivo. Int J Mol Med. 2013;32(3):629-36.

Biswas S, Rahman I. Modulation of steroid activity in chronic inflammation: a novel anti-inflammatory role for curcumin. Mol Nutr Food Res. 2008;52(9):987-94

Wu S, Xiao D. Effect of curcumin on nasal symptoms and airflow in patients with perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2016;117(6):697-702.e1.

Sahebkar A, Cicero AFG, Simental‐Mendía LE, Aggarwal BB, Gupta SC. Curcumin downregulates human tumor necrosis factor‐α levels: A systematic review and meta‐analysis of randomized controlled trials. Pharmacological Research. 2016;07:234-42.